U.K.-based pharmaceutical company GlaxoSmithKline, popularly known as GSK, signed an R&D agreement with Syngene International, a global contract research services company based in Bangalore, India. The multi-year agreement will focus on accelerating the discovery of new drug candidates with the potential to address some of the world’s most pressing healthcare needs....